Amazon launches fixed pricing to treat conditions like hair loss. Hims & Hers stock drops 15% [CNBC]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: CNBC
The move places the company in competition with other direct-to-consumer marketplaces like Hims & Hers Health and Ro. Prime members will pay for a consultation with a clinician and the medication, but there are no additional fees. Amazon on Thursday announced Prime members can access new fixed pricing to treat conditions like erectile dysfunction and men's hair loss, its latest effort to compete with other direct-to-consumer marketplaces like Hims & Hers Health and Ro. Shares of Hims & Hers fell as much as 17% Thursday, on pace for its worst day. Amazon said in a blog post that Prime members can see the cost of a telehealth visit and their desired treatment before they decide to proceed with care for five common issues. Patients can access treatment for anti-aging skin care starting at $10 a month; motion sickness for $2 per use; erectile dysfunction at $19 a month; eyelash growth at $43 a month and men's hair loss for $16 a month by using Amazon's savings benefit Prime Rx at
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Health, Inc. (NYSE: HIMS) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating.MarketBeat
- What's Going On With Hims & Hers Health Stock On Wednesday? [Yahoo! Finance]Yahoo! Finance
- Americans Continue to Struggle to Access Branded GLP-1s as Shortages ContinueBusiness Wire
- Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality [Yahoo! Finance]Yahoo! Finance
- Earnings Estimates Moving Higher for Hims & Hers Health (HIMS): Time to Buy? [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 11/4/24 - Beat
HIMS
Sec Filings
- 11/14/24 - Form 4
- 11/14/24 - Form 4
- 11/14/24 - Form 4
- HIMS's page on the SEC website